Dosage regimen design

Pharmacology & Therapeutics - Tập 17 - Trang 143-163 - 1982
C. Lindsay DeVane1, William J. Jusko2
1Division of Clinical Pharmacokinetics, College of Pharmacy, University of Florida, Gainesville, FL 32610, U.S.A.
2Department of Pharmaceutics, School of Pharmacy, State University of New York, Buffalo, NY 14260, U.S.A.

Tài liệu tham khảo

Amdisen, 1978, Clinical and serum level monitoring in lithium therapy and lithium intoxication, J. analyt. Toxic., 2, 193, 10.1093/jat/2.5.193 Benet, 1979, Noncompartmental determination of the steady-state volume of distribution, J. pharm. Sci., 68, 1071, 10.1002/jps.2600680845 Bjornsson, 1979, Estimation of kinetic parameters from a two-point determination of the drug cumulation factor, Clin. Pharmac. Ther., 26, 540, 10.1002/cpt1979265540 Borga, 1977, Plasma binding of basic drugs. I. Selective displacement from α1-acid glycoprotein by tris (2-butoxyethyl) phosphate, Clin. Pharmac. Ther., 22, 539 Brunswick, 1979, Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single dose data, Clin. Pharmac. Ther., 25, 605, 10.1002/cpt1979255part1605 Brunswick, 1980, Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr level in depressed patients, J. clin. Psychol., 41, 337 Caprani, 1975, SHAM, a method for biexponential curve resolution using initial slope, height, area, and moment of the experimental decay type curve, J. theor. Biol., 52, 299, 10.1016/0022-5193(75)90003-X Colburn, 1976, Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration, J. Pharmacokin. Biopharm., 4, 469, 10.1007/BF01064553 Cooper, 1973, The 24-hour serum lithium level as a prognosticator of dosage requirements, Am. J. Psychiat., 130, 601, 10.1176/ajp.130.5.601 Cooper, 1976, The 24-hour lithium level as a prognosticator of dosage requirements: A 2-year follow-up study, Am. J. Psychiat., 133, 440, 10.1176/ajp.133.4.440 Cooper, 1978, Prediction of individual dosage of nortriptyline, Am. J. Psychiat., 135, 333, 10.1176/ajp.135.3.333 Cotham, 1975, Spuriously low plasma propranolol concentrations resulting from blood collection methods, Clin. Pharmac. Ther., 18, 535, 10.1002/cpt1975185part1535 Danek, 1978, The use of computers in pharmacokinetics, Int. J. clin. Pharmac., 16, 345 Daniel, 1980 D'Argenio, 1979, A program package for simulation and parameter estimation in pharmacokinetic systems, Comp. Prog. Biomed., 9, 115, 10.1016/0010-468X(79)90025-4 Dawling, 1980, Nortriptyline therapy in elderly patients: dosage prediction after single dose pharmacokinetic study, Eur. J. clin. Pharmac., 18, 147, 10.1007/BF00561582 DeVane, 1979, Pharmacokinetic basis for predicting steady-state serum drug concentrations of imipramine from single dose data, Comm. Psychopharm., 3, 343 Dettli, 1971, Multiple dose kinetics and drug dosage in patients with kidney disease, Acta pharmac. toxicol. scand, 29, 211, 10.1111/j.1600-0773.1971.tb03301.x Dost, 1953 1980 Gengo, 1980, Prediction of dosage of lithium carbonate: use of a standard predictive method, J. clin. Psychol., 41, 319 Gengo, 1980, The lithium ratio as a guide to patient compliance, Comp. Psychiat., 21, 276, 10.1016/0010-440X(80)90031-0 Gibaldi, 1975 Gibaldi, 1978, Effect of plasma protein and tissue binding on the biologic half-life of drugs, Clin. Pharmac. Ther., 24, 1, 10.1002/cpt19782411 Golby, 1978, Phenytoin therapy, Clin. Pharmac. Ther., 24, 253, 10.1002/cpt1978242253 Gram, 1972, Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man, Br. med. J., 1, 463, 10.1136/bmj.1.5798.463 Gram, 1980, Relevant clinical pharmacokinetics of antidepressants Gram, 1981, 155 Jus, 1978, Pharmacokinetic interaction between amitriptyline and neuroleptics, Neuropsychobiology, 4, 305, 10.1159/000117644 Jusko, 1976, Pharmacokinetics in disease states protein binding Jusko, 1979, Surveillance of factors affecting theophylline clearances: age, tobacco, marihuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol, J. pharm. Sci., 68, 1358, 10.1002/jps.2600681106 Jusko, 1980, Guidelines for collection and pharmacokinetic analysis of drug disposition data, 639 Kaplan, 1973, Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations, J. pharm. Sci., 62, 1789, 10.1002/jps.2600621111 Koup, 1976, System for clinical pharmacokinetic monitoring of theophylline therapy, Am. J. Hosp. Pharm., 33, 949 Koup, 1979, Hypothesis for the individualization of drug dosage, Clin. Pharmacokin., 4, 460, 10.2165/00003088-197904060-00005 Kragh-Sorensen, 1976, Self-inhibiting action of nortriptyline antidepressant effect at high plasma levels, Psychopharmacologia, 45, 305, 10.1007/BF00421145 Kruger-Thiemer, 1968, Continuous intravenous infusion and multicompartment accumulation, Eur. J. Pharmac., 4, 317, 10.1016/0014-2999(68)90100-3 Kunin, 1967, A guide to use antibiotics in patients with renal disease, Ann. intern. Med., 67, 151, 10.7326/0003-4819-67-1-151 Lam, 1979, Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics, J. Pharmacokin. Biopharm., 7, 227, 10.1007/BF01059740 Lane, 1980, Prediction of steady-state behavior of metabolite from dosing of parent drug, J. Pharm. Sci., 69, 610, 10.1002/jps.2600690541 Larson, 1972, Measurement of relative blood flow, transit-time distributions and transport model parameters by residue detection when radiotracer recirculates, J. theor. Biol., 37, 503, 10.1016/0022-5193(72)90088-4 Lassen, 1979 Levy, 1968, Dose dependent effects in pharmacokinetics Lima, 1978, Pharmacokinetic approach to intravenous procainamide therapy, Eur. J. clin. Pharmac., 13, 303, 10.1007/BF00716367 Lima, 1979, Safety and efficacy of procainamide infusions, Am. J. Cardiol., 43, 98, 10.1016/0002-9149(79)90051-1 Loo, 1970, Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion, J. pharm. Sci., 59, 53, 10.1002/jps.2600590107 Ludden, 1976, Optimal phenytoin dosage regimens, Lancet, i, 307, 10.1016/S0140-6736(76)91441-0 Ludden, 1977, Individualization of phenytoin dosage regimens, Clin. Pharmac. Ther., 21, 287, 10.1002/cpt1977213287 Ludden, 1978, Rate of phenytoin accumulation in man: a simulation study, J. Pharmacokin. Biopharm., 6, 399, 10.1007/BF01062722 MacKichan, 1979, Adsorption of diazepam to plastic tubing, New Engl. J. Med., 301, 332, 10.1056/NEJM197908093010620 Mawer, 1974, Prescribing aids for gentamicin, Br. J. clin. Pharmac., 1, 45, 10.1111/j.1365-2125.1974.tb00205.x Metzler, 1974 Metzler, 1981, Estimation of pharmacokinetic parameters: statistical considerations, Pharmac. Ther., 13, 543, 10.1016/0163-7258(81)90029-2 Mitenko, 1972, Rapidly achieved plasma concentration pleateaus with observations on theophylline kinetics, Clin. Pharmac. Ther., 13, 329, 10.1002/cpt1972133329 Mitenko, 1973, Rational intravenous doses of theophylline, New Engl. J. Med., 289, 600, 10.1056/NEJM197309202891202 Montgomery, 1979, Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients, Clin. Pharmacokin., 4, 129, 10.2165/00003088-197904020-00005 Mullen, 1978, Optimal phenytoin therapy: a new technique for individualizing dosage, Clin. Pharmac. Ther., 23, 228, 10.1002/cpt1978232228 Ochs, 1978, Single and multiple-dose pharmacokinetics of oral quinidine sulfate and gluconate, Am. J. Cardiol., 41, 770, 10.1016/0002-9149(78)90830-5 Pagliaro, 1975, Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references, J. Pharmacokin. Biopharm., 3, 333, 10.1007/BF01082306 Potter, 1980, Single-dose kinetics predict steady-state concentrations of imipramine and desipramine, Archs gen. Psychiat., 37, 314, 10.1001/archpsyc.1980.01780160084010 Redmond, 1980, Single dose prediction of amitriptyline and nortriptyline requirement in unipolar depression, Curr. Ther. Res., 27, 635 Renkin, 1955, Effects of blood flow on diffusion kinetics in isolated, perfused hindlegs of cats: a double circulation hypothesis, Am. J. Physiol., 183, 125, 10.1152/ajplegacy.1955.183.1.125 Riegelman, 1968, Concept of a volume of distribution and possible errors in evaluation of this parameter, J. pharm. Sci., 57, 128, 10.1002/jps.2600570125 Riggs, 1963 Rowland, 1973, Clearance concepts in pharmacokinetics, J. Pharmacokin. Biopharm., 1, 123, 10.1007/BF01059626 Sadee, 1980 Schentag, 1977, Gentamicin disposition and tissue accumulation on multiple dosing, J. Pharmacokin. Biopharm., 5, 559, 10.1007/BF01059684 Sheiner, 1979, Forecasting Individual Pharmacokinetics, Clin. Pharmac. Ther., 26, 294, 10.1002/cpt1979263294 Slattery, 1980, A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma, J. Pharmacokin. Biopharm., 8, 105, 10.1007/BF01059452 Slattery, 1980, Prediction of maintenance dose required to attain a desired drug concentration at steady-state from a single determination of concentration after an initial dose, Clin. Pharmacokin., 5, 377, 10.2165/00003088-198005040-00005 Tallarida, 1979 Tsuchiya, 1972, Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics, J. pharm. Sci., 61, 541, 10.1002/jps.2600610409 Tsuei, 1980, Design of dosage regimens to achieve and maintain a predetermined plasma drug level range, Clin. Pharmac. Ther., 28, 289, 10.1038/clpt.1980.164 Vaughan, 1976, General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy, Eur. J. clin. Pharmac., 10, 433, 10.1007/BF00563080 Wagner, 1973, Properties of the Michaelis-Menten equation and its integrated forms which are useful in pharmacokinetics, J. Pharmacokin. Biopharm., 1, 103, 10.1007/BF01059625 Wagner, 1974, A safe method for rapidly achieving plasma concentration plateaus, Clin. Pharmac. Ther., 16, 691, 10.1002/cpt1974164691 Wagner, 1976, Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data, J. Pharmacokin. Biopharm., 4, 443, 10.1007/BF01062831 Wagner, 1978, Time to reach steady-state and prediction of steady-state concentrations for drugs obeying Michaelis-Menton elimination kinetics, J. Pharmacokin. Biopharm., 6, 209, 10.1007/BF01312263 Weinberger, 1974, Evaluation of oral bronchodilator therapy in asthmatic children, J. Pediatr., 84, 421, 10.1016/S0022-3476(74)80732-8 Wiegand, 1980, Effect of heparin on bilirubin clearance in rats: pharmacokinetic consequences of extensive hepatic extraction of plasma protein binding inhibitors, J. pharm. Sci., 69, 1228, 10.1002/jps.2600691032 Wilkinson, 1975, A physiological approach to hepatic drug clearance, Clin. pharm. Ther., 18, 377, 10.1002/cpt1975184377 Wood, 1979, Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling, Clin. Pharm. Ther., 25, 103, 10.1002/cpt1979251103 Yamaoka, 1978, Statistical moments in pharmacokinetics, J. Pharmacokin. Biopharm., 6, 547, 10.1007/BF01062109 Yeh, 1978, A comparison of numerical integrating algorithms by trapezoidal, LaGrange, and Spline approximation, J. Pharmacokin. Biopharm., 6, 79, 10.1007/BF01066064 Ziegler, 1978, Intrapatient variability of serial steady-state plasma tricyclic antidepressant concentrations, J. Pharm. Sci., 67, 554, 10.1002/jps.2600670431